Investment
Participated in Ambrosia Biosciences' $100M Series B for cardiometabolic therapeutics.
Ambrosia Biosciences
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Ambrosia Biosciences
Comeryx
RapidFort
Fund IX
Redeam